CDKN2A and cancer: In summary, these results provide the first clear indication that the cyclin-dependent kinase inhibitor p16 protein also modulates the expression of several key transcription regulators such as AUF1, E2F1 and NF-κB, and other important genes directly or indirectly involved in cancer development and spread.